In 1931 was created China Life Insurance, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Beijing. The fund was located in Asia if to be more exact in China.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular fund investment industries, there are E-Commerce, Logistics. The fund has no exact preference in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Didi Chuxing, JD Logistics, Uber China
The typical case for the fund is to invest in rounds with 6 participants. Despite the China Life Insurance, startups are often financed by Weibo, Uber, Tencent Holdings. The meaningful sponsors for the fund in investment in the same round are Tencent Holdings, China Merchants Bank, CITIC Securities. In the next rounds fund is usually obtained by China Merchants Bank, Tencent Holdings, SoftBank.
The important activity for fund was in 2016. Despite it in 2019 the fund had an activity. Deals in the range of more than 100 millions dollars are the general things for fund. Comparing to the other companies, this China Life Insurance performs on 16 percentage points less the average number of lead investments. The typical startup value when the investment from China Life Insurance is more than 1 billion dollars. The increased amount of exits for fund were in 2016. Speaking about the real fund results, this Corporate Investor is 18 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year.
We also calculated 5 valuable employees in our database.
Related Funds
Fund Name | Location |
Bangchak | Bangkok, Krung Thep, Thailand |
Bergen Asset Management | New York, New York, United States |
Fengye Capital | Beijing, Beijing, China |
FINUP | Beijing, Beijing, China |
Inco | France, Ile-de-France, Paris |
Inner Mongolia Kenuohuagai Investment Management | - |
Islamic Development Bank | Jeddah, Makkah, Saudi Arabia |
Juxi Capital | Beijing, Beijing, China |
Life.SREDA | Central, Central Region, Singapore |
Lybra | - |
MercadoLivre.com | Brazil, Santana de Parnaíba, São Paulo |
Mercato Partners | Salt Lake City, United States, Utah |
Monet Capital | California, San Jose, United States |
Olymp Capital | Luxembourg, Luxembourg |
Paradigm | Houston, Texas, United States |
Shanghai Kinetic Medical | China, Pudong |
Symvan Capital | England, London, United Kingdom |
VAMM Ventures | Dubai, United Arab Emirates |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Hanbon Sci.& Tech | $46M | 13 Jun 2022 | Huaiyin, Jiangsu, China | ||
Saint Bella | $15M | 03 Mar 2022 | Xiangzhou District, Guangdong Province, China | ||
METiS Pharmaceuticals | $86M | 13 Dec 2021 | Shangcheng District, Zhejiang, China | ||
METiS Therapeutics | $86M | 07 Dec 2021 | Cambridge, Massachusetts, United States | ||
Valgen Medtech | $100M | 06 May 2021 | Shangcheng District, Zhejiang, China | ||
$78M | 08 May 2020 | Xuanwu District, Jiangsu, China | |||
Jusda | $371M | 29 Jan 2019 | Futian District, Guangdong Province, China | ||
United Imaging Healthcare | $510M | 15 Sep 2017 | Shanghai, China | ||
Uber China | $2B | 13 Jan 2016 | Beijing, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Hanbon Sci.& Tech | $46M | 13 Jun 2022 | Huaiyin, Jiangsu, China | ||
Saint Bella | $15M | 03 Mar 2022 | Xiangzhou District, Guangdong Province, China | ||
METiS Pharmaceuticals | $86M | 13 Dec 2021 | Shangcheng District, Zhejiang, China | ||
METiS Therapeutics | $86M | 07 Dec 2021 | Cambridge, Massachusetts, United States | ||
Valgen Medtech | $100M | 06 May 2021 | Shangcheng District, Zhejiang, China | ||
$78M | 08 May 2020 | Xuanwu District, Jiangsu, China | |||
Jusda | $371M | 29 Jan 2019 | Futian District, Guangdong Province, China | ||
United Imaging Healthcare | $510M | 15 Sep 2017 | Shanghai, China | ||
Uber China | $2B | 13 Jan 2016 | Beijing, Beijing, China |